Gilternib 40 mg | Generic of Xospata (Gilteritinib)
Generic Name: Gilteritinib Dosage form : Tablets Indication: Acute Myeloid Leukemia Manufacturer: Everest Pharmaceutical
- Medically Reviewes by Dr. Daria Kwaśniewska
- WHO-GMP standards
- Instant Online Verification
Description
What is Gilternib 40 mg?
Doctors widely prescribe Gilternib 40 mg as a targeted Tyrosine Kinase Inhibitor therapy for adults with relapsed or refractory Acute Myeloid Leukemia (AML). If you are looking for Tyrosine Kinase Inhibitor prices, you may want a cost-effective Generic Gilteritinib option. This medication offers a globally recognized treatment pathway.
Clinical Equivalence: Gilternib contains Gilteritinib, the exact same active pharmaceutical ingredient used in global branded therapies like Xospata.
Clinical Equivalence: Gilternib contains Gilteritinib, the exact same active pharmaceutical ingredient used in global branded therapies like Xospata.
✔ You may consider this if:
- You have been diagnosed with Acute Myeloid Leukemia AML that has returned or did not respond to initial treatment.
- Your cancer cells have a confirmed mutation in the FLT3 gene.
- You are looking for a targeted oral therapy rather than traditional intensive chemotherapy.
❌ This may NOT be suitable if:
- You have a history of certain heart problems, specifically a prolonged QT interval.
- You are pregnant or planning to become pregnant, as this medicine can harm an unborn baby.
🔬 Quick Clinical Profile
| Clinical Parameter | Data |
|---|---|
| Active Ingredient | Gilteritinib |
| Drug Class | Tyrosine Kinase Inhibitor (FLT3 Inhibitor) |
| Standard Dosage | 120 mg (three 40 mg tablets) once daily |
| Metabolism | Hepatic (Liver) via CYP3A4 enzymes |
| Half-Life | Approximately 113 hours |
| Quality Standard | WHO-GMP standards |
🧠 Mechanism of Action
Gilternib 40 mg acts as a targeted inhibitor of a protein called FLT3. It helps stop the survival signals that cancer cells depend on to grow and multiply. By blocking these signals, it makes it harder for leukemia cells to survive. This lets your body produce healthier blood cells.
👤 Who Typically Gets Prescribed Gilternib 40 mg
This treatment approach aligns with widely used oncology practices, including guidance frameworks such as those from the NCCN.
- Adults with FLT3-mutation-positive AML that has relapsed (come back).
- Patients whose AML was refractory (did not improve) after first-line treatment.
- Patients who require a potent, second-generation FLT3 inhibitor to improve survival outcomes.
📅 First 30 Days Experience
Starting a new treatment can be overwhelming. Every patient responds differently, but many follow a similar early pattern on Gilternib 40 mg.
- Week 1: Your body begins to adjust to the medication. You may experience mild fatigue or nausea.
- Week 2–3: Your doctor will perform frequent blood tests to check your liver function and the health of your blood cells.
- Week 4: Monitoring continues for heart rhythm. Dosage adjustments may occur based on your lab results.
⚠️ Call your doctor immediately if you experience:
- Sudden trouble breathing or a rapid cough.
- Rapid weight gain or swelling in your ankles and face.
⚠️ Side Effects
Common & Manageable:
- Muscle or joint pain and general tiredness.
- Changes in liver function tests (usually monitored by blood work).
- Mild cough or mouth sores.
Less Common but Serious:
- QT prolongation: A change in the heart’s electrical rhythm. Report any dizziness or a fluttering feeling in your chest.
- Posterior reversible encephalopathy syndrome PRES: A rare brain condition. Seek help for sudden severe headaches or confusion.
- Condition called differentiation syndrome: A serious reaction where leukemia cells release inflammatory chemicals.
These effects are common in patients taking Gilternib 40 mg. They are usually manageable with early medical guidance. Always tell your care team how you are feeling.
💰 Cost, Sourcing & The “Proof Layer”
Because treatment is continuous, choosing a cost-stable generic Gilteritinib option can significantly reduce your long-term financial burden. As an international medical sourcing platform, we prioritize strict supply chain integrity.
Everest Pharmaceuticals operates under WHO-GMP standards, ensuring the highest manufacturing quality. We guarantee global shipments use verified thermal packaging to protect the medication. They also undergo strict batch code scanning to ensure authenticity.
Everest Pharmaceuticals operates under WHO-GMP standards, ensuring the highest manufacturing quality. We guarantee global shipments use verified thermal packaging to protect the medication. They also undergo strict batch code scanning to ensure authenticity.
🍽️ Administration (Practical Use)
- Dose: The standard dose is 120 mg (3 tablets) taken once daily.
- Consistency: Take your dose at the same time each day, with or without food.
- Method: You must swallow the tablets whole. Do not break, chew, or crush them.
- Missed Dose: If you miss a dose, take it as soon as you remember, unless it is within 12 hours of your next scheduled dose.
👨👩👧 Caregiver Guidance
Many patients rely heavily on their caregivers during the first few weeks of Gilternib 40 mg treatment.
- Monitor Vitals: Track daily weight and report any rapid weight gain or changes in blood pressure.
- Symptom Log: Watch for “red flags” like trouble breathing or sudden confusion.
- Safety First: Ensure the patient does not provide breast milk while on this drug and for two months after your last dose.
🔄 Treatment Adaptation
This is a known pattern with Tyrosine Kinase Inhibitor therapies. Over time, cancer cells may try to find new ways to grow. If resistance develops, your oncologist may adjust treatment or suggest new combinations based on updated mutation testing.
🔗 Need Clinical Details?
Need to know more clinical detail about Acute Myeloid Leukemia?
Read the full article on the link. Remember, this is not a medical substitute, this is just informational guideline, consult your care giver first. FLT3 mutated Acute Myeloid Leukemia.
Read the full article on the link. Remember, this is not a medical substitute, this is just informational guideline, consult your care giver first. FLT3 mutated Acute Myeloid Leukemia.
❓ FAQs (Frequently Asked Questions)
Do I need biomarker tests before starting Gilternib 40 mg?
Yes, you must have a confirmed FLT3 mutation test before starting this Gilteritinib therapy.
How quickly does Gilteritinib start working?
While it starts blocking signals immediately, it may take several weeks to see significant changes in your blood cell counts.
How long do I need to take it?
Your doctor will usually suggest taking it as long as it works. They will also want side effects to stay manageable.
Can I stop if my scans look clear?
No, you should never stop taking a TRK inhibitor without strict medical supervision, as discontinuing the therapy can allow the cancer cells to resume growing.
Can I stop if my scans look clear?
No, never stop this medication without your doctor’s permission, as the leukemia could return rapidly.
Is hair loss common with this drug class?
While some thinning can occur, complete hair loss is less common with Gilternib than with traditional chemotherapy.
This important information serves educational purposes and does not replace medical advice from your treating physician. Clinical data and indications reviewed and verified by Dr. Salma Elreedy, Clinical Oncologist.
🛒 Ready for the next step?
Tumors may eventually adapt and develop secondary mutations to bypass the medication. This is a known pattern with TRK inhibitor therapies. If resistance develops, your oncologist may adjust treatment based on mutation testing and updated genomic sequencing.
- [Check current global availability and secure shipping quotes]
- [Upload your prescription for an immediate clinical review]
- [Request transparent, wholesale pricing details today]
Be the first to review “Gilternib 40 mg | Generic of Xospata (Gilteritinib)”
You must be logged in to post a review.
Be the first to review “Gilternib 40 mg | Generic of Xospata (Gilteritinib)”
You must be logged in to post a review.
Reviews
There are no reviews yet.